Pharmaceutical Name
Bovine Rhinotracheitis-Virus Diarrhea Parainfluenza3-Respiratory Syncytial Virus Vaccine, Modified Live Virus  
 

For vaccination of healthy cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD) type 1, bovine parainfluenza3 (PI3), and bovine respiratory syncytial virus (BRSV) and BVD type 2. Vaccination of dams prior to breeding aids in the prevention of fetal infection by BVD type 1, a cause of persistent viremia in calves.

• The respiratory MLV vaccine with a non-cytopathic BVD virus which is the type reported in over 90% of field isolates* – effective for real world protection.

• Proven fetal protection against BVD type 1 – reduces the number of persistently infected calves in the herd.

• Proven broad protection against BVD type 1 and type 2.

• A true one-shot vaccination against all four diseases.
  * Data on file with Schering-Plough Animal Health Corp. 

Indications
Jencine^® 4 vaccine is for the vaccination of healthy cattle as an aid in the prevention of disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD) type 1, bovine parainfluenza3 (PI3), bovine respiratory syncytial virus (BRSV) and BVD type 2. Vaccination of dams at least 21 days prior to breeding aids in the prevention of persistently infected calves due to BVD type 1. 
 
Dosage
For further information including dose rate and complete directions and warnings, please see the Product Label by clicking here.
 
Jencine^® 4 is a registered trademark of Schering-Plough Animal Health Corporation.